These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25397678)

  • 1. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
    Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
    PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte cytokine and costimulatory molecule expression in patients infected with Leishmania mexicana.
    Carrada G; Cañeda C; Salaiza N; Delgado J; Ruiz A; Sanchez B; Gutiérrez-Kobeh L; Aguirre M; Becker I
    Parasite Immunol; 2007 Mar; 29(3):117-26. PubMed ID: 17266739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-Regulation of TLR and JAK/STAT Pathway Genes Is Associated with Diffuse Cutaneous Leishmaniasis: A Gene Expression Analysis in NK Cells from Patients Infected with Leishmania mexicana.
    Fernández-Figueroa EA; Imaz-Rosshandler I; Castillo-Fernández JE; Miranda-Ortíz H; Fernández-López JC; Becker I; Rangel-Escareño C
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004570. PubMed ID: 27031998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
    Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
    Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.
    Hernández-Ruiz J; Salaiza-Suazo N; Carrada G; Escoto S; Ruiz-Remigio A; Rosenstein Y; Zentella A; Becker I
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e871. PubMed ID: 21072232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
    Fernández-Figueroa EA; Rangel-Escareño C; Espinosa-Mateos V; Carrillo-Sánchez K; Salaiza-Suazo N; Carrada-Figueroa G; March-Mifsut S; Becker I
    PLoS Negl Trop Dis; 2012; 6(5):e1533. PubMed ID: 22629474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.
    Becker I; Salaiza N; Aguirre M; Delgado J; Carrillo-Carrasco N; Kobeh LG; Ruiz A; Cervantes R; Torres AP; Cabrera N; González A; Maldonado C; Isibasi A
    Mol Biochem Parasitol; 2003 Aug; 130(2):65-74. PubMed ID: 12946842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction.
    Cáceres-Dittmar G; Tapia FJ; Sánchez MA; Yamamura M; Uyemura K; Modlin RL; Bloom BR; Convit J
    Clin Exp Immunol; 1993 Mar; 91(3):500-5. PubMed ID: 8443970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis.
    Wilkins-Rodríguez AA; Pérez-Torres A; Escalona-Montaño AR; Gutiérrez-Kobeh L
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32312763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion.
    Diaz NL; Zerpa O; Ponce LV; Convit J; Rondon AJ; Tapia FJ
    Exp Dermatol; 2002 Feb; 11(1):34-41. PubMed ID: 11952826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ cytokines (IL-4, IL-10, IL-12, IFN-γ) and chemokines (MCP-1, MIP-1α) gene expression in human Leishmania (Leishmania) Mexicana infection.
    Valencia-Pacheco G; Loría-Cervera EN; Sosa-Bibiano EI; Canché-Pool EB; Vargas-Gonzalez A; Melby PC; Andrade-Narvaez FJ
    Cytokine; 2014 Sep; 69(1):56-61. PubMed ID: 25022962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.
    Tapia FJ; Caceres-Dittmar G; Sanchez MA; Fernandez AE; Convit J
    Biol Res; 1993; 26(1-2):239-47. PubMed ID: 7545501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils of patients with localized and diffuse cutaneous leishmaniasis: Differential response to Leishmania mexicana, with insights into mechanisms of damage inflicted upon the parasites by eosinophils.
    Salaiza-Suazo N; Porcel-Aranibar R; Cañeda-Guzmán IC; Ruiz-Remigio A; Zamora-Chimal J; Delgado-Domínguez J; Cervantes-Sarabia R; Carrada-Figueroa G; Sánchez-Barragán B; Leal-Ascencio VJ; Pérez-Torres A; Rodríguez-Martínez HA; Becker I
    PLoS One; 2024; 19(2):e0296887. PubMed ID: 38359037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma.
    Akuffo H; Maasho K; Blostedt M; Höjeberg B; Britton S; Bakhiet M
    J Infect Dis; 1997 Mar; 175(3):737-41. PubMed ID: 9041358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TLR2 and TLR4 in lesions of patients with tegumentary American leishmaniasis.
    Tuon FF; Fernandes ER; Duarte MI; Amato VS
    Rev Inst Med Trop Sao Paulo; 2012; 54(3):159-63. PubMed ID: 22634888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.
    Soto-Olguín N; Zamora-Chimal J; Delgado-Domínguez J; Becker I
    Acta Parasitol; 2023 Mar; 68(1):122-129. PubMed ID: 36434381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana.
    Satoskar A; Alexander J
    Immunology; 1995 Jan; 84(1):1-4. PubMed ID: 7890293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.